Cohen Joshua B
Reporting owner on Forms 3, 4 and 5, CIK 1898644.
Cohen Joshua B reported on 2 issuers in 2 filings, the latest a Form 4 filed 2026-11-12.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| AMLX · Amylyx Pharmaceuticals, Inc.CIK 1658551 | director, officer (Co-Chief Executive Officer) | 1 | 2026-11-12 |
| TCGX Acquisition Corp. II CIK 2149916 | director | 1 | 2026-10-20 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| AMLX · Amylyx Pharmaceuticals, Inc.Common Stock | 2026-11-09 | S sold | -38,105 | $29.3933 | 3,575,018 | Form 4 |
| AMLX · Amylyx Pharmaceuticals, Inc.Common Stock | 2026-11-09 | S sold | -61,895 | $30.1098 | 3,513,123 | Form 4 |
| TCGX Acquisition Corp. II Class B Ordinary Shares, derivative, holding | Form 3 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-458244 | Amylyx Pharmaceuticals, Inc. | 2026-11-12 | ||
| Form 3 0001898644-26-000005 | TCGX Acquisition Corp. II | 2026-10-20 |